The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes

por Frkic, Rebecca L., Richter, Katharina, Bruning, John B.
Publicado 2021

Genetic Encoding of Cyanopyridylalanine for In‐Cell Protein Macrocyclization by the Nitrile–Aminothiol Click Reaction

por Abdelkader, Elwy H., Qianzhu, Haocheng, George, Josemon, Frkic, Rebecca L., Jackson, Colin J., Nitsche, Christoph, Otting, Gottfried, Huber, Thomas
Publicado 2022

PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix

por Frkic, Rebecca L., Marshall, Andrew C., Blayo, Anne-Laure, Pukala, Tara L., Kamenecka, Theodore M., Griffin, Patrick R., Bruning, John B.
Publicado 2018

Structural and Dynamic Elucidation of a Non-acid PPARγ Partial Agonist: SR1988

por Frkic, Rebecca L., Chua, Benjamin S., Shin, Youseung, Pascal, Bruce D., Novick, Scott J., Kamenecka, Theodore M., Griffin, Patrick R., Bruning, John B.
Publicado 2018

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2

por Johansen-Leete, Jason, Ullrich, Sven, Fry, Sarah E., Frkic, Rebecca, Bedding, Max J., Aggarwal, Anupriya, Ashhurst, Anneliese S., Ekanayake, Kasuni B., Mahawaththa, Mithun C., Sasi, Vishnu M., Luedtke, Stephanie, Ford, Daniel J., O'Donoghue, Anthony J., Passioura, Toby, Larance, Mark, Otting, Gottfried, Turville, Stuart, Jackson, Colin J., Nitsche, Christoph, Payne, Richard J.
Publicado 2022